2023 international evidence-based guideline pcos glp-1 receptor agonist on the Assessment and Management of #PCOS being presented at #ENDO2023 ⁦🤩 @TheEndoSociety⁩ in Chicago, IL 🇺🇸 GLP-1 Receptor Agonists in Pregnancy

If you continue without changing your browser settings, well assume that you are happy to receive all cookies on this website

[DOI] [PubMed] [Google Scholar] 137.Nauck M.A., Friedrich N

Preclinical research shows that bitter compounds act through an extracellular odorant binding protein to inhibit sweet-responsive neurons and block the response to sweet taste, 9 making bitter herbs an important therapeutic tool in modifying dietary choices

433 Specifically, alcohol-dependent rats were administered semaglutide, which resulted in a significant reduction in their alcohol consumption

It is important to note that both orforglipron and oral semaglutide require daily administration (compared to weekly administration for the injectable drugs), and this raises the question of ideal dosing frequency for patient convenience